<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36538532</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>12</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Characteristics and predictors of Long COVID among diagnosed cases of COVID-19.</ArticleTitle><Pagination><StartPage>e0278825</StartPage><MedlinePgn>e0278825</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0278825</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0278825</ELocationID><Abstract><AbstractText Label="BACKGROUND">Long COVID or long-term symptoms after COVID-19 has the ability to affect health and quality of life. Knowledge about the burden and predictors could aid in their prevention and management. Most of the studies are from high-income countries and focus on severe acute COVID-19 cases. We did this study to estimate the incidence and identify the characteristics and predictors of Long COVID among our patients.</AbstractText><AbstractText Label="METHODOLOGY">We recruited adult (&#x2265;18 years) patients who were diagnosed as Reverse Transcription Polymerase Chain Reaction (RTPCR) confirmed SARS-COV-2 infection and were either hospitalized or tested on outpatient basis. Eligible participants were followed up telephonically after four weeks and six months of diagnosis of SARS-COV-2 infection to collect data on sociodemographic, clinical history, vaccination history, Cycle threshold (Ct) values during diagnosis and other variables. Characteristics of Long COVID were elicited, and multivariable logistic regression was done to find the predictors of Long COVID.</AbstractText><AbstractText Label="RESULTS">We have analyzed 487 and 371 individual data with a median follow-up of 44 days (Inter quartile range (IQR): 39,47) and 223 days (IQR:195,251), respectively. Overall, Long COVID was reported by 29.2% (95% Confidence interval (CI): 25.3%,33.4%) and 9.4% (95% CI: 6.7%,12.9%) of participants at four weeks and six months of follow-up, respectively. Incidence of Long COVID among patients with mild/moderate disease (n = 415) was 23.4% (95% CI: 19.5%,27.7%) as compared to 62.5% (95% CI: 50.7%,73%) in severe/critical cases(n = 72) at four weeks of follow-up. At six months, the incidence among mild/moderate (n = 319) was 7.2% (95% CI:4.6%,10.6%) as compared to 23.1% (95% CI:12.5%,36.8%) in severe/critical (n = 52). The most common Long COVID symptom was fatigue. Statistically significant predictors of Long COVID at four weeks of follow-up were-Pre-existing medical conditions (Adjusted Odds ratio (aOR) = 2.00, 95% CI: 1.16,3.44), having a higher number of symptoms during acute phase of COVID-19 disease (aOR = 11.24, 95% CI: 4.00,31.51), two doses of COVID-19 vaccination (aOR = 2.32, 95% CI: 1.17,4.58), the severity of illness (aOR = 5.71, 95% CI: 3.00,10.89) and being admitted to hospital (Odds ratio (OR) = 3.89, 95% CI: 2.49,6.08).</AbstractText><AbstractText Label="CONCLUSION">A considerable proportion of COVID-19 cases reported Long COVID symptoms. More research is needed in Long COVID to objectively assess the symptoms and find the biological and radiological markers.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2022 Arjun et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arjun</LastName><ForeName>M C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0001-7929-511X</Identifier><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Arvind Kumar</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0001-7063-7435</Identifier><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pal</LastName><ForeName>Debkumar</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2738-082X</Identifier><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Kajal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G</LastName><ForeName>Alekhya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venkateshan</LastName><ForeName>Mahalingam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Baijayantimala</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patro</LastName><ForeName>Binod Kumar</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohapatra</LastName><ForeName>Prasanta Raghab</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0002-6625-2417</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine and Critical Care, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subba</LastName><ForeName>Sonu Hangma</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.21665618</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>20</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36538532</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0278825</ArticleId><ArticleId IdType="pii">PONE-D-22-01446</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Director-General&#x2019;s opening remarks at the media briefing on COVID-19&#x2013;30 March 2020 [Internet]. 2020 [cited 2021 Dec 13]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19&#x2014;30-march-2020.</Citation></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard with Vaccination Data [Internet]. 2021.  [cited 2021 Dec 13]. Available from: https://covid19.who.int/.</Citation></Reference><Reference><Citation>World health organization. The latest on the covid-19 global situation &amp; long-term sequelae [Internet]. 2021.  [cited 2021 Dec 13]. Available from: https://www.who.int/publications/m/item/update-54-clinical-long-term-effects-of-covid-19.</Citation></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2021;93(5):2555&#x2013;6. doi: 10.1002/jmv.26624</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins FS. NIH launches new initiative to study &#x201c;Long COVID&#x201d; | National Institutes of Health (NIH) [Internet].
2021. 
Feb [cited 2021 Dec 13]. Available from: https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid.</Citation></Reference><Reference><Citation>Sifferlin A.
How Covid-19 Long Haulers Created a Movement | by Alexandra Sifferlin | Medium Coronavirus Blog. 2020. 
Nov
11 [cited 2021 Dec 13]; Available from: https://coronavirus.medium.com/how-covid-19-long-haulers-created-a-movement-24313746833a.</Citation></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. doi: 10.1016/S2213-2600(21)00031-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE.
2020. 
Dec
18 [cited 2021 Dec 13]; Available from: https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Post-COVID Conditions | CDC [Internet]. 2021 Sep [cited 2021 Dec 13]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021 [Internet]. 2021 [cited 2021 Dec 13]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A et al.. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific Reports. 2021;11(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A, Claydon VE, Limberg JK, Lucci VM, et al.. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31(3):365&#x2013;8. doi: 10.1007/s10286-021-00798-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics.
The prevalence of long COVID symptoms and COVID-19 complications&#x2014;Office for National Statistics [Internet].
2020. 
Dec [cited 2021 Dec 13]. Available from: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications.</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al.. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;31. doi: 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A.
Shadow of Long Covid: Why India needs to prepare for long-term effects of coronavirus&#x2014;Coronavirus Outbreak News.
INDIA TODAY [Internet].
2021. 
Apr
28 [cited 2021 Dec 13]; Available from: https://www.indiatoday.in/coronavirus-outbreak/story/long-covid-india-corona-cases-affects-experts-infections-post-recovery-symptoms-1795987-2021-04-28.</Citation></Reference><Reference><Citation>MoHFW | Home [Internet]. 2021 [cited 2021 Dec 13]. Available from: https://www.mohfw.gov.in/.</Citation></Reference><Reference><Citation>Dwivedi S. Coronavirus: Delhi&#x2019;s Post-Covid Clinic for Recovered Patients With Fresh Symptoms Opens. NDTV NEWS [Internet]. [cited 2021 Dec 13]; Available from: https://www.ndtv.com/delhi-news/coronavirus-delhis-post-covid-clinic-for-recovered-patients-with-fresh-symptoms-opens-2282756.</Citation></Reference><Reference><Citation>Ministry of Health and Family Welfare. National Comprehensive Guidelines for Management of PostCovid Sequelae [Internet].
2021.  [cited 2021 Dec 13]. Available from: https://www.mohfw.gov.in/pdf/NationalComprehensiveGuidelinesforManagementofPostCovidSequelae.pdf.</Citation></Reference><Reference><Citation>Indian SARS-CoV-2 Genomics Consortium (INSACOG). https://research.nibmg.ac.in/insacog/. Published 2022. Accessed September 20, 2022.</Citation></Reference><Reference><Citation>Obesity and overweight [Internet]. Who.int. 2021 [cited 18 December 2021]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.</Citation></Reference><Reference><Citation>Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF) [Internet]. 2021 Feb [cited 2021 Dec 13]. Available from: https://www.who.int/publications/i/item/global-covid-19-clinical-platform-case-report-form-(crf)-for-post-covid-conditions-(post-covid-19-crf-).</Citation></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al.. Characterising long COVID: a living systematic review. BMJ Global Health. 2021;6(9):e005427. doi: 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra N, Chowdhury M, Singh AK, Ma K, Kumar A, Ranjan P, et al.. Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India. Drug Discov Ther. 2021;15(3):156&#x2013;61. doi: 10.5582/ddt.2021.01014</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01014</ArticleId><ArticleId IdType="pubmed">34234065</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik S, Haldar SN, Soneja M, Mundadan NG, Garg P, Mittal A, et al.. Post COVID-19 sequelae: A prospective observational study from Northern India. Drug Discov Ther. 2021;15(5):254&#x2013;60. doi: 10.5582/ddt.2021.01093</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01093</ArticleId><ArticleId IdType="pubmed">34719599</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima G, Bhatt D, Idrees J, Khalid B, Mahdi F, Mehdi F. Elucidating Post-COVID-19 manifestations in India.
medRxiv [Internet].
2021.  [cited 2021 Dec 13]; Available from: https://www.medrxiv.org/content/10.1101/2021.07.06.21260115v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.06.21260115v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Budhiraja S, Aggarwal M, Wig R, Tyagi A, Mishra R, Mahajan M, et al.. Long Term Health Consequences of COVID-19 in Hospitalized Patients from North India: A follow up study of upto 12 months.
medRxiv [Internet].
2021.  [cited 2021 Dec 13]; Available from: https://www.medrxiv.org/content/10.1101/2021.06.21.21258543v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.21.21258543v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al.. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;8. doi: 10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Alcoba G, Perone SA, Courvoisier D, Chappuis F, et al.. Covid-19 symptoms: Longitudinal evolution and persistence in outpatient settings. Ann Intern Med. 2021;174(5):723&#x2013;5. doi: 10.7326/M20-5926</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5926</ArticleId><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al.. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw Open. 2021;4(2):e210830. doi: 10.1001/jamanetworkopen.2021.0830 Erratum in: JAMA Netw Open. 2021 Mar 1;4(3):e214572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav AK, Mukherjee G, Vasisht K, Bobdey S. Long COVID Among Moderate to Severe COVID-19 Cases in India During Second Wave of COVID-19 Asia Pac J Public Health. 2022. Sep 16;;10105395221124259. doi: 10.1177/10105395221124259 Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10105395221124259</ArticleId><ArticleId IdType="pmc">PMC9483130</ArticleId><ArticleId IdType="pubmed">36114710</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.GI., Brokstad K.A. Zhou F, Linchausen DW, Hansen B, et al.. Long COVID in a prospective cohort of home-isolated patients. Nat Med 27, 2021;27(9): 1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao GV, Gella V, Radhakrishna M, Kumar J, Chatterjee R, Kulkarni A v, et al.. Post-COVID-19 symptoms are not uncommon among recovered patients-A cross-sectional online survey among the Indian population.
medRxiv [Internet].
2021.  [cited 2021 Dec 13]; Available from: https://www.medrxiv.org/content/10.1101/2021.07.15.21260234v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.15.21260234v1</ArticleId><ArticleId IdType="pmc">PMC9200210</ArticleId><ArticleId IdType="pubmed">35488693</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. 2021;75(10):e14357. doi: 10.1111/ijcp.14357</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021;36:1&#x2013;13. doi: 10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwu CJ, Iwu CD, Wiysonge CS. The occurrence of long COVID: a rapid review. Pan Afr Med J 2021;38(65):1&#x2013;12. doi: 10.11604/pamj.2021.38.65.27366</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2021.38.65.27366</ArticleId><ArticleId IdType="pmc">PMC8028365</ArticleId><ArticleId IdType="pubmed">33889231</ArticleId></ArticleIdList></Reference><Reference><Citation>Anjana NK, Annie TT, Siba S, Meenu MS, Chintha S, Anish TS. Manifestations and risk factors of post COVID syndrome among COVID&#x2011;19 patients presented with minimal symptoms&#x2013;A study from Kerala, India. J Family Med Prim Care 2021;10(11):4023&#x2013;9. doi: 10.4103/jfmpc.jfmpc_851_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_851_21</ArticleId><ArticleId IdType="pmc">PMC8797119</ArticleId><ArticleId IdType="pubmed">35136762</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T, Kamholz J, Fietsam AC, Deters JR, Bryant AD. Post-COVID-19 Fatigue: Potential Contributing Factors. Brain Sci. 2020;10(12):1015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7766297</ArticleId><ArticleId IdType="pubmed">33352638</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith G.J., Morris T.T., Tudball M.J. Herbert A, Mancano G, Pike L, et al.. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11(1):5749 doi: 10.1038/s41467-020-19478-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19478-2</ArticleId><ArticleId IdType="pmc">PMC7665028</ArticleId><ArticleId IdType="pubmed">33184277</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Health Security Agency. The effectiveness of vaccination against long covid: a rapid evidence briefing. 2022.  [Cited 2022 October 30] https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-retrieve-file.pl?id=fe4f10cd3cd509fe045ad4f72ae0dfff.</Citation></Reference><Reference><Citation>Reardon S. Long COVID risk falls only slightly after vaccination, huge study shows [published online ahead of print, 2022 May 25]. Nature. 2022;10.1038/d41586-022-01453-0. doi: 10.1038/d41586-022-01453-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-01453-0</ArticleId><ArticleId IdType="pubmed">35614263</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al.. Impact of covid-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al.. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>